Formation of CDSCO’s New Intelligence Cell to keep check Illegal Activity In country’s Pharma Sector

To check illegal activities in India’s pharma sector, India’s central drug regulator CDSCO (The Central Drugs Standard Control Organisation) has formed intelligence cell of nine-member. This new cell aims to track illegal activity in the country’s pharmaceutical sector.

According to the officials, the cell has the authority to gather data on the import and export of medicines and cosmetics against the law and investigating complaints related to medicine quality received from overseas regulatory agencies.

This cell will keep tracking and check all the activities carried out in contravention to the provisions of the Drugs & Cosmetics Act, 1940, stated the order and cell will be in charge of collecting and collating information based on that.

The cell also has permissions to assist in raids in collaboration with zonal and sub-zonal offices.

Related Posts

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

New Delhi: The Parliamentary Panel on Health and Family Welfare has recommended various significant regulatory changes in the regulation of medical devices, including decentralisation of approval for all medical devices…

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory